ArticleCancers2023

Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.

Laura Pons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.